New study reveal targeted therapy working in early breast cancer
Source : https://www.eurekalert.org/pub_releases/2021-04/tuob-nsr042021.php
Targeted therapy in early stages of breast cancer can pave the way for a notable higher success rate, shows a study from the University of Bergen, Norway (UiB). PARP (Poly...
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies [ID2697]
Source : https://www.nice.org.uk/guidance/gid-ta10582/documents/html-content-2
The Appraisal Committee has prepared a Final Appraisal Document (FAD) on trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast cancer after 2 or more anti-HER2 therapies and submitted it...
Patent awarded for ULM professor's research into olive oil treatment for breast cancer
The University of Louisiana Monroe has announced a U.S. Patent has been awarded based on research led by a ULM College of Pharmacy professor. Khalid El Sayed, Ph.D., a professor...
Treatment patterns for patients with advanced/metastatic cancers by site of care - PubMed
Source : https://pubmed.ncbi.nlm.nih.gov/33877777/
Objectives: To compare treatments, overall survival (OS), and total costs among patients receiving anticancer therapy in hospital outpatient vs physician office settings. Study design: This retrospective observational study utilized claims...
-
Breast Cancer Connect5yrKey Points • In this longitudinal study published in JAMA, researchers determined 5-year locoregional recurrence-free survival (LRFS) rate and disease-free survival (DFS) rate after sentinel lymph node biopsy (SLNB) and radiotherapy (RT) Show More